Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
https://www.globenewswire.com/news-release/2024/05/02/2874160/0/en/Mineralys-Therapeutics-to-Announce-First-Quarter-2024-Financial-Results-and-Host-Conference-Call-on-Thursday-May-9-2024.html
https://www.globenewswire.com/news-release/2024/03/21/2850111/0/en/Mineralys-Therapeutics-Reports-Fourth-Quarter-and-Full-Year-2023-Financial-Results-and-Provides-Corporate-Update.html
https://www.globenewswire.com//news-release/2024/03/13/2845834/0/en/Mineralys-Therapeutics-to-Announce-Fourth-Quarter-and-Full-Year-2023-Financial-Results-and-Host-Conference-Call-on-Thursday-March-21-2024.html
https://www.globenewswire.com//news-release/2024/02/08/2825968/0/en/Mineralys-Therapeutics-Announces-120-Million-Private-Placement-Financing.html
https://www.globenewswire.com/news-release/2024/01/29/2819429/0/en/Mineralys-Therapeutics-to-Participate-in-the-Guggenheim-Securities-6th-Annual-Biotechnology-Conference.html
https://www.globenewswire.com//news-release/2024/01/04/2804310/0/en/Mineralys-Therapeutics-Appoints-Minji-Kim-Ph-D-as-Chief-Business-Officer.html
https://www.globenewswire.com//news-release/2023/12/21/2800342/0/en/Mineralys-Therapeutics-Announces-First-Subject-Dosed-in-Launch-HTN-the-Second-Pivotal-Trial-of-Lorundrostat-for-the-Treatment-of-Hypertension.html
https://www.globenewswire.com//news-release/2023/11/11/2778607/0/en/Mineralys-Therapeutics-Further-Defines-Endotype-Specific-Targeted-Approach-to-Treatment-of-Uncontrolled-or-Resistant-Hypertension-with-Lorundrostat-Data-at-AHA-Scientific-Sessions-.html
https://www.globenewswire.com//news-release/2023/11/09/2777850/0/en/Mineralys-Therapeutics-to-Participate-in-Three-Upcoming-Conferences.html
https://www.globenewswire.com//news-release/2023/11/07/2775613/0/en/Mineralys-Therapeutics-Reports-Third-Quarter-2023-Financial-Results-and-Provides-Corporate-Update.html